Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
January 1, 2025Молекулярная биология / Molecular Biology

Autophagy impairment in Parkinson’s disease: approaches to therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

TUT.S. Usenko

Discussion

Loading...

Member takes

Overview

Review uncovers targeted therapy strategies for neurotoxic effects of α-synuclein in Parkinson's disease, indicating roles of LRRK2 and autophagy.

Key Points

  • This review aims to explore the role of autophagy impairment in Parkinson's disease and potential therapeutic approaches.
  • Review of current literature on autophagy and Parkinson's disease
  • Analysis of molecular mechanisms underlying dopaminergic neuron death
  • Discussion on targeted therapy implications addressing autophagy induction.
  • Autophagy impairment leads to α-synuclein accumulation, causing neurotoxicity to dopaminergic neurons.
  • Identified roles of LRRK2 and GBA1 mutations in PD related to endolysosomal dysfunction.
  • Proposed induction of autophagy as a therapeutic intervention for PD.

Cite This Study

T.S. Usenko (2025) studied this question.

synapsesocial.com/papers/69255737c0ce034ddc35ad92https://doi.org/10.7868/s3034555325010053
View Full Paper
Ask AI
Bookmark
Share